Certificate of Analysis
Third Party Tested
Molecular Profile
Compound
Semax
Batch #
N/A
Formula
C37H51N9O10S
Mol Wt
813.9 g/mol
CAS
80714-61-0
Latest
ISO 17025
8× Testing
99.46%
Purity
VariantSemax
COA ##12724
Labeled10mg
Validation KeyAXISBIOTECH
Tested04/03/26
Full QC Panel - 8× tested
✓
Purity (HPLC) - 99.46%
✓
Net Peptide Content - 10mg
✓
Identity (HPLC) - Semax
✓
Fentanyl Screen - Not Detected
✓
HPLC Conformity mean - >99%
✓
ISO/IEC 17025 Accredited
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C long-term
2–8°C
Reconstituted
Recommended condition
Light protection
Store away from light
Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.
Peer-Reviewed Literature
Research & References
Research and reference material related to this compound.
01
Semax, an analog of ACTH(4-10) with cognitive effects
02
SEMAX affects brain BDNF and its precursor expression
03
ACTH/MSH(4-10) analog Semax with long-lasting activity: neurochemical and pharmacological properties
04
Semax stimulates expression of BDNF receptor TrkB mRNA in rat brain
05
Semax — an ACTH4-7 analog promotes angiogenesis and reduces infarct volume in rats with focal cerebral ischemia
Safety & Regulatory Compliance Warning
These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.
